SEC Filing Details

Document Details

Form
Filing Date
Jan 3, 2019
Document Date
Oct 3, 2018
Form Description
Amendment to a previously filed 8-K
Filing Group
Current Reports
Company
Theravance Biopharma, Inc.
Issuer
Theravance Biopharma, Inc.